Aroa Biosurgery Limited (ARX.AX)
AUD 0.7
(2.96%)
AUD 0.7
(2.96%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 63.35 Million | 59.3 Million | 36.88 Million | 20.51 Million | 23.82 Million | 21.76 Million |
| Cost of Revenue | 9.36 Million | 9.25 Million | 8.71 Million | 6.25 Million | 6.33 Million | 8.03 Million |
| Gross Profit | 53.98 Million | 50.05 Million | 28.16 Million | 14.25 Million | 17.49 Million | 13.72 Million |
| Operating Expenses | 66.09 Million | 58.18 Million | 39.21 Million | 28.7 Million | 20.32 Million | 13.9 Million |
| Selling, General and Administrative Expenses | 57.6 Million | 44.65 Million | 28.54 Million | 19.97 Million | 15.83 Million | 9.83 Million |
| Research and Development Expenses | 8.49 Million | 9.93 Million | 7.76 Million | 5.89 Million | 4.48 Million | 4.07 Million |
| Other Expenses | -1.52 Million | 3.3 Million | 1.15 Million | -4.3 Million | - | - |
| Cost and Expenses | 73.13 Million | 67.43 Million | 47.93 Million | 34.95 Million | 26.65 Million | 21.94 Million |
| Operating Income | -9.78 Million | -353.83 Thousand | -6.98 Million | -16.15 Million | -2.82 Million | -179.25 Thousand |
| Interest Expense | 1.16 Million | 5616.40 | 697.09 Thousand | 1.37 Million | 228.04 Thousand | 2.56 Million |
| Income Tax Expense | -1.32 Million | 11.23 Thousand | 116.18 Thousand | 98.22 Thousand | -191.93 Thousand | -3.74 Million |
| Earnings before Tax | -11.17 Million | -359.44 Thousand | -7.67 Million | -17.53 Million | -5.85 Million | -2.84 Million |
| Net Income | -9.74 Million | -370.68 Thousand | -7.79 Million | -17.63 Million | -5.66 Million | 896.26 Thousand |
| Earnings Per Share Basic | -0.03 | -0.00 | -0.02 | -0.06 | -0.02 | 0.00 |
| Earnings Per Share Diluted | -0.03 | -0.00 | -0.02 | -0.06 | -0.02 | 0.00 |
| Weighted Average Shares Outstanding | 343.82 Million | 342.91 Million | 342.16 Million | 300.4 Million | 300.07 Million | 300.07 Million |
| Weighted Average Shares Outstanding (Diluted) | 343.82 Million | 342.91 Million | 342.16 Million | 300.4 Million | 300.07 Million | 300.07 Million |
| Gross Margin | 0.85 | 0.84 | 0.76 | 0.69 | 0.73 | 0.63 |
| EBIT Margin | -0.12 | 0.05 | -0.11 | -0.65 | -0.01 | 0.08 |
| Profit Margin | -0.15 | -0.01 | -0.21 | -0.86 | -0.24 | 0.04 |
| EBITDA | -7.36 Million | 3.49 Million | -3.74 Million | -14.55 Million | -219.49 Thousand | 1.74 Million |
| Earnings Before Tax Margin | -0.15 | -0.01 | -0.19 | -0.79 | -0.12 | -0.01 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 64.02 Million | 17.05 Million | 17.24 Million | 29.46 Million | 14.68 Million | 31.27 Million |
| Cost of Revenue | 9.36 Million | 2.3 Million | 2.33 Million | 4.68 Million | 2.33 Million | 5.01 Million |
| Gross Profit | 54.65 Million | 14.75 Million | 14.91 Million | 24.78 Million | 12.35 Million | 26.26 Million |
| Operating Expenses | 66.09 Million | 17.03 Million | 17.15 Million | 30.95 Million | 15.53 Million | 28.92 Million |
| Selling, General and Administrative Expenses | - | 15.49 Million | 15.66 Million | 26.23 Million | 13.07 Million | 24.94 Million |
| Research and Development Expenses | - | 1.86 Million | 1.88 Million | 4.71 Million | 2.35 Million | 3.98 Million |
| Other Expenses | 1.71 Million | -318.27 Thousand | - | - | - | - |
| Cost and Expenses | 75.46 Million | 19.33 Million | 19.48 Million | 35.63 Million | 17.86 Million | 33.94 Million |
| Operating Income | -11.44 Million | -2.28 Million | -2.3 Million | -6.16 Million | -2.62 Million | -2.66 Million |
| Interest Expense | 1.16 Million | 233.27 Thousand | - | 220.97 Thousand | - | 180.16 Thousand |
| Income Tax Expense | -1.32 Million | 27.51 Thousand | 27.81 Thousand | 130.36 Thousand | 64.96 Thousand | -81.81 Thousand |
| Earnings before Tax | -11.17 Million | -1.95 Million | -1.97 Million | -5.7 Million | -2.84 Million | -1.9 Million |
| Net Income | -9.85 Million | -1.98 Million | -2 Million | -5.83 Million | -2.9 Million | -1.82 Million |
| Earnings Per Share Basic | - | -0.01 | -0.01 | -0.02 | -0.01 | -0.01 |
| Earnings Per Share Diluted | - | -0.01 | -0.01 | -0.02 | -0.01 | -0.01 |
| Weighted Average Shares Outstanding | 343.82 Million | 344.38 Million | 344.38 Million | 343.27 Million | 342.71 Million | 343.1 Million |
| Weighted Average Shares Outstanding (Diluted) | 343.82 Million | 344.37 Million | 344.37 Million | 343.27 Million | 343.27 Million | 343.1 Million |
| Gross Margin | 0.85 | 0.86 | 0.86 | 0.84 | 0.84 | 0.84 |
| EBIT Margin | - | -0.09 | -0.09 | -0.14 | -0.13 | -0.03 |
| Profit Margin | -0.15 | -0.12 | -0.12 | -0.20 | -0.20 | -0.06 |
| EBITDA | - | -1.49 Million | -1.51 Million | -4.18 Million | -1.85 Million | -830.05 Thousand |
| Earnings Before Tax Margin | -0.18 | -0.13 | -0.13 | -0.21 | -0.18 | -0.09 |
NVDA
OZYSR
LIN
EPIAF
MDI
1073